Calculated from a series of potential risk factors (involving the age, bilirubin and albumin levels, prothrombin time, and the existence of peripheral edema and diuretic treatment), the Mayo risk score has been commonly employed to assess the outcomes of patients with PBC [23]. The gene discussed is F2; the disease is primary biliary cholangitis.